Induction of immune tolerance using rituximab in a child with severe haemophilia B with inhibitors and anaphylaxis to factor IX

Haemophilia. 2010 Sep 1;16(5):840-1. doi: 10.1111/j.1365-2516.2007.01446.x. Epub 2010 Jun 7.

Authors

C Barnes, A Davis, J Furmedge, B Egan, L Donnan, P Monagle

PMID: 20546030
DOI: 10.1111/j.1365-2516.2007.01446.x

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Anaphylaxis / chemically induced
Anaphylaxis / prevention & control*
Antibodies, Monoclonal, Murine-Derived / therapeutic use*
Blood Coagulation Factor Inhibitors
Child
Desensitization, Immunologic / methods*
Factor IX / adverse effects
Hemophilia B / drug therapy*
Hemophilia B / immunology*
Humans
Immune Tolerance / physiology
Immunologic Factors / therapeutic use*
Immunosuppressive Agents / therapeutic use*
Male
Rituximab
Treatment Outcome

Substances

Antibodies, Monoclonal, Murine-Derived
Blood Coagulation Factor Inhibitors
Immunologic Factors
Immunosuppressive Agents
Rituximab
Factor IX